/
/
/

Prevest Denpro Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---14%
---13%
---6%-31%
18%18%18%18%

Peer Comparison

Symbol
POLYMED-A
NURECA-T
PREVEST-M
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,716₹17504 Cr55.558.4943.73₹322 Cr
346₹324 Cr74.763.216.74₹2 Cr
378.95₹461 Cr21.24.719.8₹20 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024
———
₹12 Cr₹12 Cr₹12 Cr
₹113 Cr₹94 Cr₹77 Cr
₹113 Cr₹94 Cr₹77 Cr
₹125 Cr₹106 Cr₹89 Cr
₹1 Cr₹100 L₹69 L
₹1 Cr₹100 L₹69 L
———
₹2 Cr₹2 Cr₹1 Cr
₹4 Cr₹4 Cr₹4 Cr
₹34 L₹9 L₹35 L
₹7 Cr₹6 Cr₹6 Cr
₹133 Cr₹113 Cr₹95 Cr
———
₹37 Cr₹35 Cr₹33 Cr
₹10 Cr₹8 Cr₹6 Cr
₹27 Cr₹27 Cr₹27 Cr
₹27 Cr₹27 Cr₹27 Cr
———
₹9 Cr₹5 Cr₹2 Cr
₹11 Cr₹8 Cr₹6 Cr
₹9 Cr₹8 Cr₹8 Cr
₹73 Cr₹61 Cr₹49 Cr
₹92 L₹1 Cr₹8 L
₹4 Cr₹3 Cr₹3 Cr
₹106 Cr₹86 Cr₹68 Cr
₹99 Cr₹80 Cr₹63 Cr
₹133 Cr₹113 Cr₹95 Cr
₹104₹88₹74
₹104₹88₹74

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024
₹28 Cr₹24 Cr₹21 Cr
-₹2 Cr-₹2 Cr-₹1 Cr
-₹4 Cr-₹2 Cr-₹4 Cr
₹21 Cr₹21 Cr₹16 Cr
₹15 Cr₹15 Cr₹12 Cr
-₹2 Cr-₹1 Cr-₹2 Cr
-₹1 Cr-₹1 Cr-₹32 L
₹12 Cr₹12 Cr₹10 Cr
₹61 Cr₹49 Cr₹39 Cr
-₹6 L₹0₹0
₹73 Cr₹61 Cr₹49 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)383.70
Volume (₹)10,600.00
High (₹)383.70
Upper Circuit460.40
Low (₹)372.00
Lower Circuit307.00
Prev Close383.70
52W High (₹)559.90
Price378.95
52W Low (₹)318.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)460.56 Cr
Div. Yield (%)0.26
PE Ratio21.20
Debt to Equity0.00
Price to Book3.29
Book Value103.97
EPS (TTM)18.10
Face Value10.00
ROE (%)17.79

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
POLYMED-ANSE
NURECA-TNSE
PREVEST-MNSE
LTP
1W Low
1W High
Market cap (₹)
1716-11.75 (-0.68%)
1693.45
1771.75
17,504Cr
346+3.6 (1.05%)
330.05
358
324Cr
378.95-3.35 (-0.88%)
372
388.90
461Cr

Prevest Denpro Ltd Annual Results Key Takeaways

Cost mix (full year): raw materials ₹17.82Cr; employee cost ₹8.65Cr; depreciation ₹52.2Lakh; other expenses ₹12.3Cr. Basis: consolidated annual results.

Prevest Denpro Ltd Quaterly Results Key Takeaways

Prevest Denpro Ltd reported ₹19.07Cr total income from operations in Jun 2026, softer than ₹18.94Cr in Mar 2026 but higher than ₹15.77Cr in Jun 2025. After tax of ₹1.92Cr, profit after tax stood at ₹5.64Cr (vs ₹5.82Cr in Mar 2026 and ₹4.41Cr in Jun 2025).